AU Stock MarketDetailed Quotes
FRE Firebrick Pharma Ltd
- 0.053
- +0.001+1.92%
20min DelayNot Open Nov 22 15:51 AET
11.14MMarket Cap-7571P/E (Static)
0.053High0.053Low9.21KVolume0.053Open0.052Pre Close488.00Turnover0.11052wk High0.01%Turnover Ratio210.11MShares0.04552wk Low-0.007EPS TTM5.79MFloat Cap0.750Historical HighLossP/E (Static)109.21MShs Float0.036Historical Low-0.007EPS LYR0.00%Amplitude--Dividend TTM5.30P/B1Lot Size--Div YieldTTM
About Firebrick Pharma Ltd Company
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.
Company Profile
SymbolFRE
Company NameFirebrick Pharma Ltd
Founded2012
MarketASX
Fiscal Year Ends06-30
Address440 Collins Street Level 10
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 1300301874
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Peter Laurence Molloy
- Founder,Chief Executive Officer,Executive Chairman,Executive Director
- --
- Stephen Francis Goodall
- Founder,Chief Operating Officer,Executive Director
- --
- Richard Spencer Treagus
- Non-Executive Director
- --
- Phyllis Irene Gardner
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data